|
Exchange Received Time  03/11/2018 11:38:38 Exchange Disseminated Time 03/11/2018 11:38:45 Time Taken 00:00:07 | MANGALAM DRUGS has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2018 ,inter alia, to consider and approve 1. To approve, consider and take on record the Un-audited Financial Results along with Limited review report of the company for the quarter and half year ended 30th September, 2018 as prescribed under Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 2. Any other matters with the permission of the chair. |
|
|